Results 41 to 50 of about 1,309,506 (180)

Dose‐related propofol resistance in COVID‐19 patients: Altered drug plasma levels, mechanistic insights from neuronal‐derived extracellular vesicles and miRNA analysis

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim Critical care for COVID‐19 patients presents unique challenges, particularly in sedation management. Patients demonstrate notable dose‐related resistance to propofol, potentially due to complex pharmacokinetic alterations. Emerging evidence suggests that plasma extracellular vesicle‐associated miRNA represents valuable predictive ...
Debora Curci, Carlotta Bidoli, Marco Gerdol, Charisse Winston, Robert A. Rissman, Giuliana Decorti, Antonella Fabretto, Andrea Taddio, Gabriele Stocco, Erik Roman‐Pognuz, Marianna Lucafò   +10 more
wiley   +1 more source

Ondansetron and metoclopramide as second-line antiemetics in women with nausea and vomiting in pregnancy: the EMPOWER pilot factorial RCT

Health Technology Assessment, 2021
Background: Around one-third of pregnant women suffer from moderate to severe nausea and vomiting, causing physical and emotional distress and reducing their quality of life. There is no cure for nausea and vomiting in pregnancy.
Stephen Robson, Catherine McParlin, Helen Mossop, Mabel Lie, Cristina Fernandez-Garcia, Denise Howel, Ruth Graham, Laura Ternent, Alison Steel, Nicola Goudie, Afnan Nadeem, Julia Phillipson, Manjeet Shehmar, Nigel Simpson, Derek Tuffnell, Ian Campbell, Rew Williams, Margaret E O’Hara, Elaine McColl, Catherine Nelson-Piercy   +19 more
doaj   +1 more source

Patient‐reported outcomes and medication errors during oral antitumour therapy in paediatrics: Results from the youngAMBORA care programme

British Journal of Clinical Pharmacology, EarlyView.
Aim Increasing use of oral antitumour therapeutics (OAT) in paediatrics is associated with numerous advantages, but also with error‐prone aspects. Based on the randomized AMBORA trial including adults treated with various OAT, we developed a tailored pharmacological/pharmaceutical care programme for children and their caregivers during OAT treatment ...
Phyllis Lensker, Lisa Cuba, Frank Dörje, Martin F. Fromm, Markus Metzler   +4 more
wiley   +1 more source

Helping patients discuss CINV management : development of a patient charter [PDF]

, 2013
In April 2012, an Expert Group of specialist cancer nurses working in a variety of settings (e.g. chemotherapy delivery, chemotherapy service design, research, nurse leadership and patient information/advocacy) participated in telephone/web-based ...
Dielenseger, Pascale, O’Donovan, Eileen, Jones, Philippa, Lennan, Elaine, Sharp, Sue, Whiteford, Alison, Fernandez Ortega, Paz, Fernandez Perez, Dolores, Young, Annie M., Wiles, Lilian, Fernández Pérez, María Dolores   +10 more
core   +1 more source

Development of resue antiemetic guidelines for the management of chemotherapy induced nausea and vomiting in paediatric patients at the RHSC, Edinburgh

, 2011
Our obbjective is to review and update the existing local antiemetic guidelines at the Royal Hospital for Sick Children (RHSC) Haematology/Oncology Department, Edinburgh in line with current best practice and produce evidence based rescue antiemetic ...
Johnson, Julienne, Kinnear, Moira, Zingel, J, Hudson, Stephen, Ferguson, J   +4 more
core   +2 more sources

A systemic review on chemotherapy induced nausea and vomiting- risk and clinical management with alternative therapies

Cancer Treatment and Research Communications
Chemotherapy-induced nausea and vomiting (CINV) affects up to 80 % of cancer patients, significantly impacts the health in terms of their quality of life and straining healthcare resources. CINV is categorized into anticipatory, acute, and delayed types.
Derangula Lavanya, VelugotlaPranathi Prasanna, Asma Firdous, Sneha Thakur   +3 more
doaj   +1 more source

Expert Consensus on Effective Management of Chemotherapy-Induced Nausea and Vomiting: An Indian Perspective

Frontiers in Oncology, 2020
Chemotherapy-induced nausea and vomiting (CINV) is one of the most common and feared side effects in cancer patients undergoing chemotherapy. Scientific evidence proves its detrimental impact on a patient's quality of life (QoL), treatment compliance ...
Ashok K. Vaid, Sudeep Gupta, Dinesh C. Doval, Shyam Agarwal, Shona Nag, Poonam Patil, Chanchal Goswami, Vikas Ostwal, Sagar Bhagat, Saiprasad Patil, Hanmant Barkate   +10 more
doaj   +1 more source

Exploring women's experiences and perceptions regarding the pharmacological management of hyperemesis gravidarum: a qualitative study

Journal of Pharmacy Practice and Research, EarlyView.
Abstract Background Hyperemesis gravidarum (HG) is a severe form of nausea and vomiting in pregnancy with potential sequelae including hypovolaemia, electrolyte imbalance, and malnutrition, which can result in adverse maternal–foetal outcomes. Aim To explore Australian women's experiences and perceptions regarding the pharmacological management of HG ...
Timothy R. McNamara, Jacqueline H. Stephens, Stefan C. Kane, Emma L. Healy, Caitlin Neville, Luke E. Grzeskowiak   +5 more
wiley   +1 more source

Oregon sentencing guidelines implementation manual [PDF]

, 1989
Title from PDF cover (viewed on May 22, 2019).Guidelines developed by the Oregon Criminal Justice Council and revised by the State Sentencing Guidelines Board.Includes January 1992 Supplement.This archived document is maintained by the State Library of ...

core  

Development of resue antiemetic guidelines for the management of chemotherapy induced nausea and vomiting in paediatric patients at the RHSC, Edinburgh

, 2010
Our obbjective is to review and update the existing local antiemetic guidelines at the Royal Hospital for Sick Children (RHSC) Haematology/Oncology Department, Edinburgh in line with current best practice and produce evidence based rescue antiemetic ...
Hudson, S, J. Ferguson, Kinnear, M, S. Hudson, Johnson, Julienne, M. Kinnear, Johnson, J, Kinnear, Moira, Zingel, J, J. Johnson, Hudson, Stephen, Ferguson, J, J. Zingel   +12 more
core   +1 more source